This study suggests that elucidation of the interaction between mitochondria, endoplasmic reticulum and LDs and its regulatory mechanism through the Drp1–FLNA complex can lead to new therapeutic strategies for fatty liver disease such as NAFLD/NASH. Here, FLNA is linked to metabolic dysfunction-associated steatohepatitis.